Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
53 / 100
AltIndex AI Score
Hold
AI Score · 12-mo trend
+3 pts over 3 months
FundamentalsBullish
TechnicalsBearish
Alternative dataBullish
SentimentNeutral
Price$0.46
Year Range$0.46 – $0.98
Market Cap$2.3M
PE Ratio0.5
IndustryBiotechnology

What Is Oragenics’s AI Stock Analysis?

Oragenics’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Oragenics’s momentum in near-real time.

Oragenics (OGEN) has an AltIndex AI Score of 53/100, currently a Hold signal. The AI Score distills Oragenics's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.

Oragenics’s Full AI Analysis

Oragenics, Inc. is a biopharmaceutical company engaged in the research and development of innovative therapies for oral health and infectious diseases. The company's primary focus lies in producing novel antibiotics against infectious diseases and developing effective treatments for oral mucositis. With a strong research base and various products in different development stages, Oragenics aims to leverage its scientific edge to cater to unmet medical needs.

Fundamental Analysis

Net income for the last quarter stood at $2.5 million, a decrease of 14.88% compared to the previous quarter. This decline raises concerns, suggesting potential operational inefficiencies or challenges. Compared to the same quarter last year, there is a net income decrease of 11.30%, which may signify persistent underlying issues.

Premium

Keep reading AltIndex’s full AI analysis of Oragenics — the fundamental, technical and alternative-data breakdown and the recommendation.

Sign up to read the full analysis

What’s Driving OGEN’s AI Score?

Fundamentals

Net income for the last quarter was $-2.5M. This represents a decrease of 14.88% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 11.30%, which may be a cause for concern. Ebitda for the last quarter was $-2.6M. This represents a decrease of 16.23% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 51.81%, which may be a cause for concern. The current P/E ratio is 0.5. This may be considered low, potentially indicating undervaluation and a bullish outlook.

See Oragenics’s earnings and insider transactions.

Technicals

Today's stock price is $0.46. This represents a decrease of 11.54% compared to a month ago, which may be concerning in the short-term. However, compared to a year ago, there is a decrease of 64.62%, which could be a cause for long-term concern. The trend is bearish. The current SMA10 is $0.49, which is lower than the previous SMA10 of $0.49. This suggests a potential downward trend in price movement. The RSI is 52.1, indicating a neutral condition.

See the full technical analysis and price prediction.

Alternative data

Oragenics has an estimate of 4,000 visitors to their webpage. The number of visitors is up by 100% in the last couple of months, a bullish trend as this can indicate can increase in customers.

Explore Oragenics’s job postings, web traffic and app downloads.

Frequently Asked Questions: Oragenics AI Stock Analysis

Oragenics's AltIndex AI Score is 53/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.

AltIndex's AI Score model rates Oragenics a Hold (53/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.

The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.

AltIndex generates a complete written AI analysis of Oragenics — company overview, fundamentals, technicals and alternative data, with a recommendation. See the OGEN AI Score or sign up to read the full thesis.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.